Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Buy
65
ZBH Quote, Financials, Valuation and Earnings
Last price:
$92.86
Seasonality move
:
4.81%
Day range:
$92.38 - $93.92
52-week range:
$85.33 - $114.44
Dividend yield:
1.02%
P/E ratio:
23.28x
P/S ratio:
2.34x
P/B ratio:
1.46x
Volume:
1.6M
Avg. volume:
2M
1-year change:
-8.56%
Market cap:
$18.6B
Revenue:
$7.7B
EPS (TTM):
$4.04
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings, Inc.
|
$2.2B | $2.39 | 9.9% | 100.01% | $102.70 |
|
EW
Edwards Lifesciences Corp.
|
$1.5B | $0.62 | 10.91% | 9.41% | $96.44 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.7B | $2.25 | 12.86% | 19.35% | $608.26 |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.7M | -- | -57.64% | -57.14% | $2.30 |
|
RMD
ResMed, Inc.
|
$1.4B | $2.71 | 8.96% | 16.17% | $291.80 |
|
SYK
Stryker Corp.
|
$7.1B | $4.39 | 10.64% | 210.62% | $427.22 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings, Inc.
|
$94.08 | $102.70 | $18.6B | 23.28x | $0.24 | 1.02% | 2.34x |
|
EW
Edwards Lifesciences Corp.
|
$85.13 | $96.44 | $49.4B | 36.24x | $0.00 | 0% | 8.51x |
|
ISRG
Intuitive Surgical, Inc.
|
$586.24 | $608.26 | $207.8B | 77.60x | $0.00 | 0% | 22.18x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.88 | $2.30 | $44.2M | -- | $0.00 | 0% | 2.91x |
|
RMD
ResMed, Inc.
|
$250.92 | $291.80 | $36.6B | 25.68x | $0.60 | 0.9% | 7.02x |
|
SYK
Stryker Corp.
|
$367.21 | $427.22 | $140.4B | 48.22x | $0.88 | 0.93% | 5.82x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings, Inc.
|
38.87% | -0.623 | 41.53% | 1.20x |
|
EW
Edwards Lifesciences Corp.
|
6.42% | -0.043 | 1.55% | 2.86x |
|
ISRG
Intuitive Surgical, Inc.
|
-- | 1.051 | -- | 3.42x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.64% | 3.209 | 0.6% | 3.40x |
|
RMD
ResMed, Inc.
|
12.15% | 0.549 | 2.12% | 1.89x |
|
SYK
Stryker Corp.
|
44.02% | 0.442 | 12.35% | 0.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings, Inc.
|
$1.3B | $330.7M | 4.11% | 6.45% | 16.52% | $267.7M |
|
EW
Edwards Lifesciences Corp.
|
$1.2B | $433.1M | 12.34% | 13.19% | 27.89% | $516.2M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.7B | $759.7M | 16.35% | 16.38% | 30.33% | $735.6M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$1.5M | -$1.4M | -83.42% | -89.54% | -50.02% | -$1.5M |
|
RMD
ResMed, Inc.
|
$808.9M | $462.3M | 22.25% | 25.6% | 34.62% | $411.5M |
|
SYK
Stryker Corp.
|
$3.7B | $1.4B | 7.89% | 14.06% | 22.52% | $1.4B |
Zimmer Biomet Holdings, Inc. vs. Competitors
-
Which has Higher Returns ZBH or EW?
Edwards Lifesciences Corp. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of 18.82%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat Edwards Lifesciences Corp.'s return on equity of 13.19%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B EWEdwards Lifesciences Corp.78.29% $0.50 $10.9B -
What do Analysts Say About ZBH or EW?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.70, signalling upside risk potential of 9.16%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $96.44 which suggests that it could grow by 13.29%. Given that Edwards Lifesciences Corp. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe Edwards Lifesciences Corp. is more attractive than Zimmer Biomet Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 18 1 EWEdwards Lifesciences Corp.16 12 0 -
Is ZBH or EW More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.616, which suggesting that the stock is 38.41% less volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.955, suggesting its less volatile than the S&P 500 by 4.496%.
-
Which is a Better Dividend Stock ZBH or EW?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or EW?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are larger than Edwards Lifesciences Corp. quarterly revenues of $1.6B. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is lower than Edwards Lifesciences Corp.'s net income of $292.3M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.28x while Edwards Lifesciences Corp.'s PE ratio is 36.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 8.51x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.28x $2B $231.2M EWEdwards Lifesciences Corp.8.51x 36.24x $1.6B $292.3M
-
Which has Higher Returns ZBH or ISRG?
Intuitive Surgical, Inc. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of 28.31%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B ISRGIntuitive Surgical, Inc.66.36% $1.95 $17B -
What do Analysts Say About ZBH or ISRG?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.70, signalling upside risk potential of 9.16%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $608.26 which suggests that it could grow by 3.76%. Given that Zimmer Biomet Holdings, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe Zimmer Biomet Holdings, Inc. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 18 1 ISRGIntuitive Surgical, Inc.14 11 1 -
Is ZBH or ISRG More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.616, which suggesting that the stock is 38.41% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.867%.
-
Which is a Better Dividend Stock ZBH or ISRG?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or ISRG?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.5B. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is lower than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.28x while Intuitive Surgical, Inc.'s PE ratio is 77.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 22.18x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.28x $2B $231.2M ISRGIntuitive Surgical, Inc.22.18x 77.60x $2.5B $709.2M
-
Which has Higher Returns ZBH or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of -59.08%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B NMTCNeuroOne Medical Technologies Corp.55.77% -$0.03 $7.3M -
What do Analysts Say About ZBH or NMTC?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.70, signalling upside risk potential of 9.16%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.30 which suggests that it could grow by 162.56%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Zimmer Biomet Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 18 1 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is ZBH or NMTC More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.616, which suggesting that the stock is 38.41% less volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.575, suggesting its less volatile than the S&P 500 by 42.534%.
-
Which is a Better Dividend Stock ZBH or NMTC?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or NMTC?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are larger than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is higher than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.28x while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 2.91x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.28x $2B $231.2M NMTCNeuroOne Medical Technologies Corp.2.91x -- $2.7M -$1.6M
-
Which has Higher Returns ZBH or RMD?
ResMed, Inc. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of 26.1%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat ResMed, Inc.'s return on equity of 25.6%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B RMDResMed, Inc.60.56% $2.37 $7B -
What do Analysts Say About ZBH or RMD?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.70, signalling upside risk potential of 9.16%. On the other hand ResMed, Inc. has an analysts' consensus of $291.80 which suggests that it could grow by 16.29%. Given that ResMed, Inc. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe ResMed, Inc. is more attractive than Zimmer Biomet Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 18 1 RMDResMed, Inc.8 7 1 -
Is ZBH or RMD More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.616, which suggesting that the stock is 38.41% less volatile than S&P 500. In comparison ResMed, Inc. has a beta of 0.876, suggesting its less volatile than the S&P 500 by 12.416%.
-
Which is a Better Dividend Stock ZBH or RMD?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. ResMed, Inc. offers a yield of 0.9% to investors and pays a quarterly dividend of $0.60 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. ResMed, Inc. pays out 22.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or RMD?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are larger than ResMed, Inc. quarterly revenues of $1.3B. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is lower than ResMed, Inc.'s net income of $348.5M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.28x while ResMed, Inc.'s PE ratio is 25.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 7.02x for ResMed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.28x $2B $231.2M RMDResMed, Inc.7.02x 25.68x $1.3B $348.5M
-
Which has Higher Returns ZBH or SYK?
Stryker Corp. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of 14.18%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat Stryker Corp.'s return on equity of 14.06%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B SYKStryker Corp.61.86% $2.22 $38.9B -
What do Analysts Say About ZBH or SYK?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.70, signalling upside risk potential of 9.16%. On the other hand Stryker Corp. has an analysts' consensus of $427.22 which suggests that it could grow by 16.34%. Given that Stryker Corp. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe Stryker Corp. is more attractive than Zimmer Biomet Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 18 1 SYKStryker Corp.13 7 0 -
Is ZBH or SYK More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.616, which suggesting that the stock is 38.41% less volatile than S&P 500. In comparison Stryker Corp. has a beta of 0.890, suggesting its less volatile than the S&P 500 by 10.974%.
-
Which is a Better Dividend Stock ZBH or SYK?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. Stryker Corp. offers a yield of 0.93% to investors and pays a quarterly dividend of $0.88 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. Stryker Corp. pays out 41.74% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or SYK?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are smaller than Stryker Corp. quarterly revenues of $6.1B. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is lower than Stryker Corp.'s net income of $859M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.28x while Stryker Corp.'s PE ratio is 48.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 5.82x for Stryker Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.28x $2B $231.2M SYKStryker Corp.5.82x 48.22x $6.1B $859M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
